Senegal Becomes First African Country to Locally Manufacture Generic Sickle Cell Treatment
Senegal has made a major breakthrough in the fight against sickle cell disease, becoming the first African country to locally manufacture a generic treatment for the condition. The medicine, branded DREPAF, is a generic version of hydroxyurea, a widely used treatment that can help reduce painful crises, hospitalisations and the need for blood transfusions among…
